Geovax Labs Stock News

Interim data from a Phase 2 clinical trial of LY-CoV555 shows a reduction in the rate of hospitalization in patients treated with the antibody.

The FDA granted emergency authorization of convalescent plasma to treat hospitalized COVID-19 patients on Sunday, and this could be helpful in treating sick people, former...

COVID-19 era highlights U.S. 'black hole' compensation fund for pandemic vaccine injuries

The number of confirmed cases of the coronavirus that causes COVID-19 in the U.S. rose above 4.8 million on Thursday, a day after President Donald Trump...

Many Nigerians have come to the conclusion that inadequate electricity supply in the country is one of the factors inhibiting national growth.

Javadekar said the government isconsidering merging film units of the Information and Broadcasting Ministry like Children's Film Society and Films Division into one entity so that existing resources c

In another reversal of the decisions taken by the previous Fadnavis government, Maharashtra Vikas Aghadi (MVA) government on Friday scrapped the pension scheme meant for the...

The Maharashtra chief minister’s firm stance on several issues has surprised allies Congress and NCP

PT PLN (Persero) Unit Induk Pembangunan Nusa Tenggara (UIP Nusra) segera menuntaskan pembangunan lima gardu induk untuk memperkuat keandalan sistem ...

ATLANTA, GA, June 10, 2020 -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious.

ATLANTA, GA, June 04, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --GeoVax Labs, Inc. (GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and canc

ATLANTA, GA, May 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (GOVX), a biotechnology company developing human vaccines, today announced its financial results for the three mon

ATLANTA, GA, April 30, 2020 -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTC: GOVX), a biotechnology company developing human vaccines and immunotherapies against infectious.

ATLANTA, GA, March 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --GeoVax Labs, Inc. (GOVX), a biotechnology company developing human vaccines and immunotherapies against infectious diseases and ca

ATLANTA, GA, March 25, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and ca